Financials
- Market Capitalization 92.72 M
- Employee 78
- Founded 2006
- CEO Lindsay Rosenwald
- Website www.fortressbiotech.com
- Headquarter Delaware, United States
- FIGI BBG001J2MFH6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-52.29
Relación precio/flujo de caja
1.61
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3938 | CGTX Cognition Therapeutics, Inc. - Common Stock | 1.06 USD | 0.00% | +4.95% | +15.22% | -58.75% | 100.80 M USD | ||
| 3947 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.10 USD | +0.49% | 0.00% | +23.49% | -59.92% | 97.60 M USD | ||
| 3976 | PYPD PolyPid Ltd. - Ordinary Shares | 5.11 USD | -0.20% | +1.59% | +21.38% | +51.63% | 93.02 M USD | ||
| 3978 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.54 USD | 0.00% | -1.28% | -2.53% | -73.72% | 92.90 M USD |